BACKGROUND: Obesity is a severe health problem worldwide, which leads to multiple comorbidities including type 2 diabetes mellitus and cardiovascular diseases. Inflammation has been found to be an important characteristic of adipose tissue in obese subjects. However, obesity is also associated with compromised immune responses to infections and the impact of obesity on immune function has not been fully understood. SUBJECTS/METHODS: To clarify the role of obesity in the immune responses, we investigated the Toll-like receptor (TLR)-induced cytokine secretion by leukocytes from obese and lean subjects. We also investigated the relationship between insulin-induced intracellular signaling and cytokine production using peripheral blood mononuclear cells (PBMCs) and a monocytic cell line THP-1. RESULTS: We found decreased TLR-induced interferon-γ, interleukin-6 (IL-6) and tumor necrosis factor-α secretions and elevated IL-10 secretion by leukocytes from obese subjects when compared with lean controls. PBMCs from obese subjects showed enhanced basal Akt and glycogen synthase kinase-3β (GSK-3β) phosphorylation, which did not further increase with insulin and lipopolysaccharide (LPS) stimulation. We also found that LPS-induced IκBα degradation was inhibited in PBMCs from obese subjects. By using THP-1 cells with GSK-3β knockdown or cells treated with hyperinsulinemic and high-fatty acid conditions, we found that LPS-induced nuclear factor κB (NF-κB) activation was inhibited and cyclic adenosine monophosphate response element-binding protein (CREB) activation was enhanced. CONCLUSIONS: These findings indicate that GSK-3β is important in the regulation of NF-κB and CREB activation in leukocytes under the metabolic condition of obesity. Our study revealed a key mechanism through which metabolic abnormalities compromise leukocyte functions in people with obesity.
INTRODUCTION
Obesity is a modern epidemic, which often leads to type 2 diabetes mellitus (DM) and cardiovascular complications including coronary artery diseases and stroke. 1 Inflammation has been found to be an important characteristic of adipose tissues in obese subjects. 2 Elevated serum glucose, insulin, triglyceride and free fatty acid levels in obesity have been reported to induce the production of pro-inflammatory cytokines. 3, 4 These obesityassociated inflammatory conditions are believed to aggravate the various complications of obesity. However, obesity is also associated with compromised immune responses to infections. 5, 6 Patients with increased body mass index (BMI) have higher incidence of infection by many prevalent pathogenic microorganisms. 7, 8 In animal studies, mice fed with a high-fat diet have been shown to have compromised adaptive immunity against influenza virus infections and increased susceptibility to bacterial infections. 9, 10 How the metabolic conditions cause the seemingly paradoxical changes in immune responses in obese subjects still remains to be fully understood.
Pattern recognition receptors including Toll-like receptors (TLRs) on innate immune cells have been found to be crucial in inducing cytokine secretion in infection. 11 TLRs detect diverse pathogen-associated molecular patterns and activate immune cells to defend against various microorganisms. 11 TLR-induced cytokine profiles, therefore, have been used to determine whether the host immune cells respond adequately to various infections. 12 In obesity conditions, excessive nutrition and high insulin level in the tissue milieu were reported to lead to abnormal TLR signaling and leukocyte activation. 13, 14 Previous studies showed that glycogen synthase kinase-3β (GSK-3β), a downstream molecule of the insulin-mediated phosphatidylinositol 3-OH kinase activation signaling pathway, participates in the modulation of TLR-induced cytokine secretion from monocytes by changing the balance of pro-inflammatory and anti-inflammatory states. 15, 16 Although it has long been known that obesity induces elevated GSK-3β activity in fat tissue, 17 the activation status of GSK-3β in leukocytes of people with obesity is still unknown. Based on the hypothesis that GSK-3β may participate in the dysregulated TLR signaling in obese people, we examined TLR-induced cytokine secretions and GSK-3β phosphorylation in resting and activated leukocytes from normal and metabolically abnormal obese subjects. We also investigated the role of metabolic changes of obesity on leukocyte activation to unravel the immune mechanisms underlying this secondary immunodeficiency of worldwide importance.
MATERIALS AND METHODS Subjects
Twenty-one obese subjects (aged 32.8 ± 2.2 years) were recruited from National Cheng Kung University Hospital (NCKUH), Tainan, Taiwan. We included subjects with metabolically abnormal obesity who met all three of the following criteria: (1) BMI greater than 25 kg m − 2 , (2) male waist ⩾ 90 cm or female ⩾ 80 cm, (3) two or more of the following metabolic syndrome factors: fasting glucose more than 100 mg dl − 1 , high-density lipoprotein less than 50 mg dl − 1 in female or less than 40 mg dl − 1 in male, triglyceride more than 150 mg dl − 1 and systolic blood pressure more than 130 mm Hg or diastolic BP more than 85 mm Hg. Sixteen lean subjects (aged:31.9 ± 1.0 years) with BMI less than 23 kg m − 2 and no positivity of the metabolic syndrome factors were recruited. All subjects were negative for underlying diseases and the blood samples were drawn before any weight loss medications. Exclusion criteria included current smokers, alcohol consumers (more than two drinks per day), diagnosis of inflammatory disease or cancer, and use of hormone replacement therapy. 18 The study protocol was approved by the NCKUH Institutional Research Review Board.
Reagents and antibodies
Sodium palmitate, bovine serum albumin (BSA) and lithium chloride were purchased from Sigma-Aldrich (St Louis, MO, USA). Human recombinant insulin, RPMI-1640 and fetal bovine serum were from Invitrogen (Grand Island, NY, USA). TLR agonists were from Invivogen (San Diego, CA, USA). Antibodies used for immunoblotting included anti-P-Akt (S473), anti-Akt and anti-IκBα (Epitomics, Burlingame, CA, USA); anti-P-GSK-3β (Ser9, Cell signaling, Danvers, MA, USA); anti-GSK-3β (GenTex, lton Parkway Irvine, CA, USA); and anti-actin (Sigma-Aldrich). Anti-NF-κB p65 (BioLegend, San Diego, CA, USA) and anti-P-cyclic adenosine monophosphate response element-binding protein (CREB (S133, Epitomics) were used in immunofluorescence imaging.
TLR-induced cytokine secretion by stimulated blood cells
Heparinized whole blood samples from lean and obese subjects were diluted 1:3 with RPMI-1640 without supplements. Diluted blood samples were then stimulated with TLR agonists including TLR1/2 (0.2 μg ml − 1 of Pam3CSK4), TLR2 (10 8 cells per ml of heat-killed Listeria monocytogenes), TLR4 (10 μg ml − 1 of lipopolysaccharide (LPS)) and TLR6/2 (1 μg ml − 1 of FLS-1 (Pam2CGDPKHPKSF)) within 3 h after blood sampling. Supernatants were collected after 18 and 48 h of stimulation and stored at − 80°C. For cytokine measurement, interleukin-12 (IL-12) and tumor necrosis factor-α (TNF-α) were detected from 18-h supernatants and IL-6, IL-10 and interferon-γ (IFN-γ) were detected in 48-h supernatants. Quantification of cytokine level was performed by Bio-plex suspension array kit (Bio-Rad Laboratories, Hercules, CA, USA) and Luminex 200 system (Luminex Corporation, Austin, TX, USA) according to the manufacturer's instructions. The total leukocyte counts and differential counts were quantified in each blood sample and the cytokine production was standardized by the number of peripheral blood mononuclear cell (PBMC) to 10 6 PBMCs in each milliliter of blood as previously reported. 19 
PBMCs preparation and treatment
Heparinized blood samples were collected from lean and obese subjects. PBMCs were isolated with Ficoll-paque by following the manufacturer's instructions. Cells were suspended to 1 × 10 6 cells per ml with RPMI-1640 without fetal bovine serum after isolation. After resting at room temperature for 2 h, PBMCs were stimulated with insulin (20 μg ml − 1 ) or LPS (1 μg ml − 1 ) for 15, 30 and 60 min. Cell lysates were collected and stored at − 80°C for SDS-polyacrylamide gel electrophoresis (SDS-PAGE) analysis. We analyzed four to six subjects in each group based on the availability of the blood samples from the subjects. Akt, GSK-3β phosphorylation and IκBα levels were detected with western blotting and immune detection as previously described. 20 
BSA-palmitate preparation
Palmitate was solubilized in ethanol as stock of 50 mM. BSA-palmitate complex was freshly prepared before each experiment. BSA was dissolved in RPMI-1640 at 250 mg ml − 1 , pH = 7.4. BSA-palmitate complex was prepared by mixing palmitate and BSA in 1:4 and incubated at 37°C for 15 min.
Cell culture and treatment
The THP-1 cells were cultured at 37°C in RPMI-1640 supplemented with 10% (v/v) heat-inactivated fetal bovine serum. Phorbol-myristate-acetate (Sigma-Aldrich) was used to differentiate THP-1 in density of 1 × 10 6 cells per ml. Adherent cells were collected after 24 h of incubation. To mimic hyperinsulinemic or high free fatty acid conditions, THP-1 cells were treated with insulin (Invitrogen), palmitate (100 μM, BSA conjugated) or insulin and palmitate for 24 h. Equivalent amount of BSA was used as vehicle controls. For LPS-induced cytokine secretion with GSK3β inhibition, THP-1 cells were stimulated with LPS (1 μg ml − 1 ) for 24 h with or without lithium chloride (LiCl), 20 mM pre-treatment. Cell lysates were then harvested with or without LPS (1 μg ml − 1 , 1 h) stimulation.
SDS-PAGE and western blot analysis
Cell lysates were harvested from PBMCs (1 × 10 6 per ml) of lean and obese subjects or differentiated THP-1 cells with 100 μl of lysis buffer (1% Triton X-100, 150 mM NaCl, 10 mM Tris base, 1 mM EDTA, 1 mM EGTA, 50 × protease inhibitor cocktail, pH 7.4). After 8% SDS-PAGE analysis, western blots using different antibodies (P-Ser473-Akt, total Akt, P-Ser9-GSK-3β, total GSK-3β, IκBα and β-actin) were performed. The signal was developed with enhanced chemiluminescence reagents. For quantitative analysis, images were analyzed with ImageJ (National Institutes of Health, Bethesda, MD, USA).
Lentiviral targeting GSK-3β for gene knockdown
The short hairpin RNA (shRNA) clones TRCN0000010551 (5′-CACTGGTCACGTTTGGAAAGA-3′) targeted against human GSK-3β were purchased from the National RNAi Core Facility (Institute of Molecular Biology/Genomic Research Center, Academia Sinica, Taiwan). Lentivirus particles containing the shRNA sequences were prepared and used to infect cells as previously described. 21 In brief, we transduced THP-1 cells with lentivirus packed with shRNA-expressing vector targeting GSK-3β (shGSK-3β) and control (shLuc) in complete growth medium supplemented with polybrene (Sigma-Aldrich). After 24 h of transducing, puromycin selection was performed and GSK-3β protein expression was analyzed with SDS-PAGE and western blots.
Immunofluorescence analysis
Differentiated THP-1 cells with or without GSK-3β knockdown were seeded on cover slides. Cells were then fixed and permeabilized by 4% paraformaldehyde and permeabilization buffer with 0.1% Triton X-100 and 0.05% SDS for 15 min and stained with antibodies to nuclear factor κB (NF-κB) p65 or P-CREB for 1 h, followed by the incubation with AlexaFluor 488-conjugated goat anti-rabbit antibody. The nuclei were visualized with 4',6-diamidino-2-phenylindole staining. Images were acquired with Nikon C1-Si confocal microscope (Nikon, Tokyo, Japan). Images were then analyzed with ImageJ and TissueQuest cell analysis software (Tissue Genostics, Vienna, Austria) to quantify the mean fluorescence intensity in cytoplasmic and nuclear regions of the cells. Positivity of nuclear localization of NF-κB or P-CREB was characterized by negative cytoplasmic signal and positive nuclear signal in individual cells.
Chromatin immunoprecipitation
THP-1 cells (5 × 10 6 cells in 10 ml) with or without GSK-3β knockdown were treated with LPS (1 μg ml − 1 ) for 1 h, and chromatin immunoprecipitation assays were performed. Briefly, proteins-DNA was cross-linked with 1% fresh prepared formaldehyde for 15 min. Then 125 mM glycine was used to block the function of formaldehyde. Cells were lysed with cell lysis buffer supplemented with protease inhibitor cocktail. Chromatin was sheared by sonification with nuclear lysis buffer. The sheared chromatin was precleared for 40 min with protein G-agarose and immunoprecipitation was then performed overnight at 4°C using antibodies against NF-κB p65 or P-CREB. Immunoprecipitates were collected with protein G-agarose and washed with low-salt buffer, high-salt buffer, LiCl buffer and TE buffer, respectively. Proteins-DNA cross-links were separated for 2 h at 65°C and then 2 h at 57°C with proteinase K. DNA was phenol/chloroform-extracted, ethanol-precipitated and used for PCR. DNA isolated from total nuclear extract was used as input control. To detect IL-6, TNF-α or IL-10 promoter in the processed samples, PCR was carried out with forward primer: 5′-CCTAGTTGTGTCTTGCGATG-3′, reverse primer: 5′-GGAGGGGAGA TAGAGCTTCT-3′ for IL-6 promoter; forward primer: 5′-ATATGGCCACACAC TGGGGC-3′, reverse primer: 5′-GGGCTTGGTGGCAGGCTTGA-3′ for TNF-α promoter region, and forward primer:
5′-CTCCCCAGGAAATCAACT-3′ and reverse primer: 5′-AAAAGCCACAATCAAGGT-3′ for IL-10 promoter region.
Statistics
Statistical analyses were carried out with Prism 5.0. The mean values from each group were compared by Student's t-test or by one-way analysis of variance. In all tests, P-values of less than 0.05 were considered statistically significant.
RESULTS

Demographic and clinical characteristics of the study groups
The demographic and clinical data of the subjects are detailed in Table 1 . The age and sex of the obese group were comparable to those of the lean control group. The BMI level in the obese group, as expected, was significantly higher than that in the lean group. The serum triglyceride, cholesterol, low-density lipoprotein levels were higher while high-density lipoprotein level was lower in the obese group in comparison with the lean group. The parameters for glucose homeostasis, including fasting glucose, HbA1C and insulin levels, were all significantly higher in obese subjects than those in the lean subjects. The most marked differences between lean and obese groups were in insulin (3.0 ± 0.4 mIU ml − 1 vs 20.7 ± 3.9 mIU ml − 1 , P = 0.0003) and triglyceride levels (68.3 ± 4.9 mg dl − 1 vs 154.8 ± 17.1 mg dl − 1 , P o 0.0001).
We also found that in the obese group, the total leukocyte counts were higher but the immune cell compositions were similar when compared with the lean group ( Supplementary Figure 1) .
Decreased IFN-γ, IL-6, TNF-α and increased IL-10 secretion by TLR-stimulated whole blood samples from obese subjects We investigated the cytokine secretion by leukocytes induced by different TLR-agonist stimulations using diluted whole blood samples from the subjects of obese and lean groups. Only results from stimulating TLR1/2, TLR2/6, TLR2 and TLR4, which induced significant secretion of cytokines, are shown. Stimulated blood cells from obese subjects produced significantly lower level of IFN-γ with or without TLR-agonists stimulations when compared with those in lean subjects (Figure 1a ). Stimulated blood cells from obese subjects also showed lower IL-6 secretion after TLR-agonist stimulations (Figure 1b ). TNF-α levels after TLR1/2 and TLR2/6 stimulation were also significantly lower in obese subjects when compared with lean subjects (Figure 1c ). On the contrary, stimulated blood cells from obese subjects produced significantly higher levels of IL-10 after TLR1/2-, TLR2-and TLR4-agonist stimulations when compared with those in lean subjects ( Figure 1d ). There were no significant differences in IL-12 secretion between lean and obese subjects (data not shown).
Mononuclear leukocytes of obese subjects had elevated basal Akt and GSK-3β phosphorylation, which did not further increase after insulin and LPS stimulation We went on to investigate the molecular mechanisms underlying this change in leukocyte response in obesity. We focused on Phosphorylation of GSK3-β in obesity affects cytokine production GSK-3β, which have been shown to be a critical molecule for both insulin and TLR agonist-induced signaling pathways. 15 PBMCs have been reported to be the major source of cytokines of interest (IFN-γ, TNF-α, IL-6 and IL-10), which were differentially induced in the whole blood samples from obese and lean groups after stimulation. 22, 23 We hence used PBMC for the following experiments. We first analyzed the basal Ser9 GSK-3β phosphorylation in PBMCs of lean and obese subjects with SDS-PAGE and western blots. We found that the basal level of GSK-3β phosphorylation was elevated in obese subjects when compared with the level in lean subjects (Figures 2a and b ). We then analyzed Akt Ser473 and GSK-3β Ser9 phosphorylation in PBMCs treated with or without insulin or LPS from lean and obese subjects. Both insulin and LPS induced Akt and GSK-3β phosphorylation in lean subjects after the stimulation (Figure 2c ). However, we found no significant induction of Akt and GSK-3β phosphorylation by insulin or LPS in the obese group (Figure 2c ). We next compared the relative quantity of phosphorylated Akt and GSK-3β in insulin-and LPSstimulated leukocytes from the lean and obese subjects. We found that in the lean group Akt phosphorylation was significantly induced by insulin and LPS at 15 or 60 min, whereas GSK-3β phosphorylation was strongly enhanced with insulin and LPS stimulation for 30 min. In contrast, the relative intensity of phosphorylated Akt and GSK-3β in the obese group before stimulation was higher than those in the lean group and did not significantly change after insulin and LPS stimulation (Figure 2d ). These findings suggested that metabolic changes in obesity may enhance the phosphorylation of Akt and GSK-3β and compromise insulin-and LPS-induced signaling in leukocytes.
Decrease in LPS-induced IκBα degradation in PBMCs of obese subjects and in monocytic cells treated with high-insulin and high-free fatty acid conditions We then investigated the TLR-induced NF-κB activation in leukocytes of lean and obese subjects. We analyzed the degradation of IκBα, which is an important regulator of NF-κB activation, in PBMCs of lean and obese subjects. In PBMCs of lean subjects, IκBα levels decreased after LPS stimulation in a timedependent manner (Figure 3 ). However, this IκBα degradation induced by LPS was not apparent in PBMCs of obese subjects. There was no significant difference in the basal levels of IκBα between lean and obese subjects (P = 0.159). These findings suggested that NF-κB activation after TLR stimulation is compromised in PBMCs isolated from obese subjects.
To clarify the role of GSK-3β in obese condition, we treated differentiated human monocytic cells THP-1 with insulin or saturated free fatty acid palmitate or both for 24 h to mimic the hyperinsulinemic and hyperlipidemic condition in obesity. We used monocytic cells in this study because previous study showing that cytokine secretions from whole blood samples were more strongly correlated with monocytic cytokines than cytokines produced from PBMC. 24 As previous studies showed that serumfree fatty acid levels positively correlated with serum triglyceride levels, 25 we used insulin and palmitate to mimic hyperinsulinemic and hyperlipidemic conditions in obesity based on our findings of markedly increased serum insulin and triglyceride levels in obese subjects (shown in Table 1 ). After 24 h, THP-1 cells treated with insulin, palmitate or both showed increased GSK-3β phosphorylation and increased IκBα level when compared with the control group (Figure 3c ). Moreover, insulin and palmitate treatment inhibited LPS-induced IκBα degradation (Figure 3d ). These findings suggested that enhanced GSK-3β phosphorylation under hyperinsulinemic and high free fatty acid condition may compromise NF-κB activation through inhibiting IκBα degradation in activated leukocytes.
Inhibition of GSK-3β decreased LPS-induced NF-κB activation but increased CREB activation
To further investigate whether GSK-3β participates in the regulation of LPS-induced NF-κB activation, we established GSK-3β-knockdown THP-1 cells using lentiviral delivery of genespecific shRNA. NF-κB nuclear translocation induced by LPS in normal and GSK-3β-deficient cells was analyzed with confocal microscopy. Our results showed that LPS-induced NF-κB nuclear translocation was inhibited in cells with shRNA targeting GSK3β (Figure 4a ). NF-κB nuclear translocation in THP-1 cells was also inhibited by co-treatment of insulin and palmitate (Figure 4a ). The quantitative results showed that 73.2 ± 7.4% of control cells with LPS stimulation had NF-κB nuclear localization. The proportion of cells with NF-κB nuclear translocation with LPS stimulation declined to 36.5 ± 23.8% when cells were treated with insulin and palmitate. GSK-3β knockdown also inhibited LPS-induced NF-κB nuclear translocation to 37.3 ± 12.9%. Given that GSK-3β regulates IκBα level in leukocytes under obese condition, these findings on NF-κB nuclear translocation indicated that GSK-3β phosphorylation on serine9, which is functionally equivalent to lack of GSK-3β, inhibits NF-κB activation. GSK-3β has also been linked to regulation of CREB, which inhibits NF-κB activation and promotes anti-inflammatory cytokine IL-10 secretion. 26 We found that P-CREB (Ser133) in the nucleus after LPS stimulation was enhanced in cells with GSK3β knockdown (Figure 4b ). Insulin and palmitate pretreatment also enhanced LPS-induced CREB phosphorylation. Taken together, we found that cell treatment with hyperinsulinemic and high free fatty acid and GSK-3β knockdown both inhibited LPS-induced NF-κB activation and enhanced CREB activation.
To test the role of GSK-3β in TLR-induced cytokine secretion, we stimulated differentiated THP-1 cells with LPS with or without GSK-3β inhibitor LiCl pretreatment. Supernatants were harvested after 24 h of incubation. LPS-induced IL-6 and TNF-α secretions were inhibited with LiCl pretreatment ( Supplementary Figures 2A  and B) . At the same time, LiCl enhanced LPS-induced IL-10 secretion (Supplementary Figure 2C) . These results supported the role of GSK-3β on the regulation of NF-κB and CREB activation along with pro-inflammatory and anti-inflammatory cytokine secretion.
We then performed chromatin immunoprecipitation assay to investigate the promotor-binding activity of NF-κB and CREB by analyzing the association of NF-κB with the TNF-α promoter region and CREB with IL-10 promoter region after LPS stimulation in cells with or without GSK-3β knockdown. We found that LPS stimulation induced NF-κB binding to TNF-α promoter region and P-CREB to IL-10 promoter region in control cells. GSK-3β knockdown inhibited the binding of NF-κB to TNF-α promoter region but enhanced P-CREB association with IL-10 promoter region (Figures 4c and d) . We conclude from these results that GSK-3β activity regulates NF-κB and CREB nuclear translocation and promotor binding activity differently in response to LPS stimulation.
DISCUSSION
By investigating the immunological and metabolic changes in non-diabetic patients with obesity, we found that elevated serum insulin and lipid levels in obese conditions may dampen TLRinduced NF-κB activation and cytokine secretion by inducing GSK-3β phosphorylation. Our results indicate that GSK-3β, the key downstream signaling molecule of insulin stimulation, is a pivotal molecule in downregulating TLR stimulation-induced inflammatory response. These findings revealed a novel role of GSK-3β as a central molecule in compromising the immune responses in metabolically abnormal obese people.
Although chronic inflammation state has been known to be one of the key characteristics of metabolic syndrome including obesity and type 2 DM, people with metabolic syndrome are also known for their poor response to bacterial and viral infections. 27, 28 We previously reported that type 2 DM patients with Mycobacterium tuberculosis infection have more severe tuberculosis infections, which require longer treatment and are more likely to develop multidrug-resistant tuberculosis. 29 In the 2009 pandemic of influenza A/H1N1 virus infection, studies from several countries found that obese (BMI ⩾ 30) and morbidly obese patients (BMI ⩾ 40) were more likely to develop pneumonitis compared with non-obese patients. 30 However, the immunopathological mechanism through which obesity affects early immune responses to microbial stimulation in humans is still unclear. In this study, we used fresh whole blood samples in cytokine production experiments in order to keep the leukocytes in conditions closer to their original in vivo metabolic states. We found that the induced production of IFN-γ, IL-6 and TNF-α decreased but the production of IL-10 increased in blood stimulated with TLR-agonists in obese subjects. The shift of TLR-induced cytokine profile from proinflammatory to anti-inflammatory appears to reflect the aberrant responses of first-line immune cells, which lead to the susceptibility to severe infection in obese subjects. The higher blood leukocyte counts in the obese group ( Supplementary Figure 1) might compensate for the lower production of pro-inflammatory cytokines but at the same time enhance the higher antiinflammatory cytokine production to a certain extent. Interestingly, elevated IL-10 production can also be found in endurance athletes, who are another group of people who have special metabolic conditions and exhibit increased susceptibility to common opportunistic infections. 31 In type 2 DM, the immunodeficient condition is often attributed to glucose toxicity. 32, 33 However, it has been difficult to clearly separate the effects of hyperinsulinemia and glucose toxicity in patients with diabetes. In this study, the serum triglyceride and insulin levels of obese subjects were 2.3-folds and 7.0-folds higher than the levels in lean control subjects, whereas the blood glucose . Hyperinsulinemic and high fatty acid condition and GSK-3β knockdown inhibited LPS-induced NF-κB activation and enhanced LPS-induced P-CREB activation. Differentiated THP-1 cells were infected with control and GSK-3β-shRNA lentivirus or treated with insulin and palmitate and then stimulated with LPS for 1 h. NF-κB (a) and P-CREB (b) were visualized by immunofluorescence staining and confocal microscopy. Higher magnification of cells indicated by the arrow heads were shown on the inset diagrams. The percentages of nuclear positive cells in three independent experiments are showed as percentage and standard deviation below. The experiments were repeated twice with similar results. Chromatin immunoprecipitation (ChIP) analysis was performed to show the binding of p65 NF-κB to TNF-α (c) and P-CREB to IL-10 promoter regions (d). The ChIP experiments were repeated three times with similar results. level was still below the diabetic range. The high insulin and triglyceride levels with relatively normal glucose concentrations in obese subjects without type 2 DM in this study therefore provided an opportunity to distinguish the high insulin and lipid effects from glucose toxicity. Our data hence suggest that the immunosuppressive effect of obesity through Akt-GSK-3β signaling can be independent of glucose toxicity in non-diabetic obese patients.
The effects of hyperinsulinemia on immune cells have been investigated in previous studies. Kidd et al. showed that LPSinduced inflammation can be inhibited by insulin-induced Akt activation. 34 As a main hormone for regulating glucose metabolism in hepatocytes and muscle cells, insulin at high concentrations enhances glucose uptake and inhibit gluconeogenesis through the Akt-GSK-3β signaling pathway. 35 High insulin levels, however, have also been found to inhibit leukocyte activation. Insulin, hence, has been used in treatment for septic shock based on its anti-inflammatory action. 36 Long-term exposure to high levels of free fatty acids has also been known to alter macrophage function. 37 Our findings in this study indicate that chronic hyperinsulinemia and high free fatty acid conditions in obese people may induce a persistent and strong signal through GSK-3β pathway, which is also a signal pathway activated by TLR stimulation. Our study thus for the first time pinpointed the importance of this molecular change in leukocyte response and showed how this change may become apparent in obese patients before the development of full-blown DM.
Previous studies have shown that Akt-GSK-3β signaling is an important regulator of cytokine secretion in several infectious diseases. 16, 38 Martin et al. showed that GSK-3β phosphorylation promotes CREB activation and inhibits NF-κB activation with TLR stimulation. 15 Mechanistically, GSK-3β can phosphorylate CREB at Ser129 to deactivate CREB. 39 Their findings are compatible with the immunodeficient state in obese people and are consistent with our results showing that inhibition of GSK3β through chemical suppression or gene knockdown reduces TLR-induced NF-κB activation and enhances CREB activation. Ahmad et al. found that the level of cytokines including TNF-α and IL-6 were higher in PBMCs of obese subjects. 40 Previous study indicated that adipose tissues can produce increased amount of TNF-α in obese people. 41 In our study, we found that serum TNF-α levels were significantly higher in obese subjects than in lean subjects. Meanwhile, the serum IFN-γ and IL-6 levels were comparable in lean and obese group ( Supplementary Figure 3 ). Although these findings appear to be in contradiction of the results showing lower levels of pro-inflammatory cytokine production in this study, our ex vivo stimulation-induced cytokine production shown in Figure 1 represents the cytokine production by leukocytes and early leukocyte responses to microbial molecule stimulation rather than the baseline serum levels, which are much lower than the measurements in the stimulated samples. Our results in this study, hence, indicate that in addition to chronic systemic inflammation, weakened immune responses to TLR stimulation is an overlooked consequence of systemic metabolic changes in obese subjects.
Our findings show that hyper-stimulation of Akt-GSK-3β signaling and direct inhibition of GSK-3β may change the balance of the pro-and anti-inflammatory responses induced by TLR stimulations suggest a model of interaction between these two important signal pathways in immune cells ( Figure 5 ). In lean subjects with normal insulin and free fatty acid levels, which lead to lower Akt and GSK3β phosphorylation states, TLR stimulation induces a pro-inflammatory response, which effectively turns on the defense machinery against invading microorganisms. In obese subjects, hyper-stimulation by insulin and fatty acid induces a phosphorylated, and hence a deactivated, state of GSK3β, which leads to an ineffective cytokine response to TLR stimulations. Additional investigation will be needed to reveal the detailed pathways through which GSK-3β facilitates the degradation of IκBα. Moreover, how GSK-3β phosphorylation is induced in the obese condition need to be further characterized given that previous reports have shown that other protein kinases including protein kinase C, which can be activated by the treatment with free fatty acids, can also phosphorylate GSK-3β. 42, 43 Various strategies have been developed for anti-obesity or antidiabetes therapy. Some anti-diabetic agents have been shown to have anti-GSK3β activity. 44 Moreover, systemic inhibition of GSK3β has been suggested as therapeutic strategy for metabolic syndrome. 45 Based on the understanding on the role of Akt-GSK-3β signaling on immune functions in obese people revealed in this study, it is quite likely that the immunity against microbial infections in obese people may be further suppressed by these medications with anti-GSK3β activity. The treatments for obesity and diabetes, which may affect GSK3β activity, hence, should take the immunomodulating effects into consideration. Figure 5 . Obesity-induced changes in leukocyte signals revealed in this study. Chronic hyperinsulinemia and high free fatty acid conditions in obesity cause hyperstimulation signals through the Akt-GSK-3β signaling pathway, which is a shared signal pathway with TLR stimulation. The persistently high phosphorylation level of GSK-3β in leukocytes, which keeps GSK-3β in an inactive state may promote CREB activation and inhibit NF-κB activation, resulting in altered cytokine production after TLR stimulation. FFA, free fatty acids; IKK, IκB kinase; IR, insulin receptor; PAMP, pathogen-associated molecular pattern; PKC, protein kinase C.
In conclusion, hyperinsulinemia and hyperlipidemia in obesity may impair TLR-induced pro-inflammatory responses but promote anti-inflammatory cytokine IL-10 secretion by enhancing GSK3β phosphorylation and dampening NF-κB-mediated activation in leukocytes. Our study provides a novel mechanism through which metabolic abnormalities in obesity lead to compromised leukocyte response to microbial stimulation in a state of chronic inflammation.
